Aspect Biosystems secures $115m to develop tissue therapeutics
Aspect Biosystems has secured $115m in a Series B financing round to advance the development of bioprinted tissue therapeutics.
Aspect Biosystems has secured $115m in a Series B financing round to advance the development of bioprinted tissue therapeutics.
What's Your Reaction?
